Corbus Pharmaceuticals Holding Inc. buy BiotechBee
Start price
15.04.24
/
70%
€38.80
Target price
30.06.26
€50.00
Performance (%)
-62.37%
End price
14.12.24
€14.60
Summary
This prediction ended on 14.12.24 with a price of €14.60. Massive losses of -62.37% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corbus Pharmaceuticals Holding Inc. | -1.921% | -1.921% | 63.774% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
According to BiotechBee what are the pros and cons of Corbus Pharmaceuticals Holding Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Corbus Pharmaceuticals Holdings Inc diskutieren
Buy mit Kursziel 50,0